Clinical trial
Chemo-embolization for Head and Neck Cancer
NCT04595981 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemo-embolization for Head and Neck Cancer
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- May 31, 2027
- Completion date
- May 31, 2030
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
scchn, squamous cell carcinoma